First major opioid trial takes aim at pharmaceutical giant Johnson & Johnson
The state of Oklahoma is suing Johnson and Johnson, claiming the pharmaceutical company "falsely downplayed the risk of opioid addiction." "CBS This Morning" consumer investigative correspondent Anna Werner joins CBSN with more on the case.
